Binding, Thermodynamics, and Selectivity of a Non-peptide Antagonist to the Melanocortin-4 Receptor

The melanocortin-4 receptor (MC4R) is a potential drug target for treatment of obesity, anxiety, depression, and sexual dysfunction. Crystal structures for MC4R are not yet available, which has hindered successful structure-based drug design. Using microsecond-scale molecular-dynamics simulations, w...

Full description

Bibliographic Details
Main Authors: Noureldin Saleh, Gunnar Kleinau, Nicolas Heyder, Timothy Clark, Peter W. Hildebrand, Patrick Scheerer
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-06-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2018.00560/full
id doaj-6aa741c50a304af09e5f0b05cbb74b76
record_format Article
spelling doaj-6aa741c50a304af09e5f0b05cbb74b762020-11-24T23:15:44ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122018-06-01910.3389/fphar.2018.00560370881Binding, Thermodynamics, and Selectivity of a Non-peptide Antagonist to the Melanocortin-4 ReceptorNoureldin Saleh0Noureldin Saleh1Gunnar Kleinau2Gunnar Kleinau3Nicolas Heyder4Nicolas Heyder5Timothy Clark6Peter W. Hildebrand7Peter W. Hildebrand8Peter W. Hildebrand9Patrick Scheerer10Patrick Scheerer11Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Institute of Medical Physics and Biophysics, Berlin, GermanyComputational Modelling and Dynamics of Molecular Complexes, Berlin, GermanyCharité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Institute of Medical Physics and Biophysics, Berlin, GermanyGroup Protein X-ray Crystallography and Signal Transduction, Berlin, GermanyCharité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Institute of Medical Physics and Biophysics, Berlin, GermanyGroup Protein X-ray Crystallography and Signal Transduction, Berlin, GermanyComputer-Chemie-Centrum, Department of Chemistry and Pharmacy, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, GermanyCharité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Institute of Medical Physics and Biophysics, Berlin, GermanyComputational Modelling and Dynamics of Molecular Complexes, Berlin, GermanyInstitute of Medical Physics and Biophysics, Leipzig University, Leipzig, GermanyCharité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Institute of Medical Physics and Biophysics, Berlin, GermanyGroup Protein X-ray Crystallography and Signal Transduction, Berlin, GermanyThe melanocortin-4 receptor (MC4R) is a potential drug target for treatment of obesity, anxiety, depression, and sexual dysfunction. Crystal structures for MC4R are not yet available, which has hindered successful structure-based drug design. Using microsecond-scale molecular-dynamics simulations, we have investigated selective binding of the non-peptide antagonist MCL0129 to a homology model of human MC4R (hMC4R). This approach revealed that, at the end of a multi-step binding process, MCL0129 spontaneously adopts a binding mode in which it blocks the agonistic-binding site. This binding mode was confirmed in subsequent metadynamics simulations, which gave an affinity for human hMC4R that matches the experimentally determined value. Extending our simulations of MCL0129 binding to hMC1R and hMC3R, we find that receptor subtype selectivity for hMC4R depends on few amino acids located in various structural elements of the receptor. These insights may support rational drug design targeting the melanocortin systems.https://www.frontiersin.org/article/10.3389/fphar.2018.00560/fullMC4Rmelanocortin-4 receptormelanocortin-receptorsligand bindingligand selectivitymolecular dynamics
collection DOAJ
language English
format Article
sources DOAJ
author Noureldin Saleh
Noureldin Saleh
Gunnar Kleinau
Gunnar Kleinau
Nicolas Heyder
Nicolas Heyder
Timothy Clark
Peter W. Hildebrand
Peter W. Hildebrand
Peter W. Hildebrand
Patrick Scheerer
Patrick Scheerer
spellingShingle Noureldin Saleh
Noureldin Saleh
Gunnar Kleinau
Gunnar Kleinau
Nicolas Heyder
Nicolas Heyder
Timothy Clark
Peter W. Hildebrand
Peter W. Hildebrand
Peter W. Hildebrand
Patrick Scheerer
Patrick Scheerer
Binding, Thermodynamics, and Selectivity of a Non-peptide Antagonist to the Melanocortin-4 Receptor
Frontiers in Pharmacology
MC4R
melanocortin-4 receptor
melanocortin-receptors
ligand binding
ligand selectivity
molecular dynamics
author_facet Noureldin Saleh
Noureldin Saleh
Gunnar Kleinau
Gunnar Kleinau
Nicolas Heyder
Nicolas Heyder
Timothy Clark
Peter W. Hildebrand
Peter W. Hildebrand
Peter W. Hildebrand
Patrick Scheerer
Patrick Scheerer
author_sort Noureldin Saleh
title Binding, Thermodynamics, and Selectivity of a Non-peptide Antagonist to the Melanocortin-4 Receptor
title_short Binding, Thermodynamics, and Selectivity of a Non-peptide Antagonist to the Melanocortin-4 Receptor
title_full Binding, Thermodynamics, and Selectivity of a Non-peptide Antagonist to the Melanocortin-4 Receptor
title_fullStr Binding, Thermodynamics, and Selectivity of a Non-peptide Antagonist to the Melanocortin-4 Receptor
title_full_unstemmed Binding, Thermodynamics, and Selectivity of a Non-peptide Antagonist to the Melanocortin-4 Receptor
title_sort binding, thermodynamics, and selectivity of a non-peptide antagonist to the melanocortin-4 receptor
publisher Frontiers Media S.A.
series Frontiers in Pharmacology
issn 1663-9812
publishDate 2018-06-01
description The melanocortin-4 receptor (MC4R) is a potential drug target for treatment of obesity, anxiety, depression, and sexual dysfunction. Crystal structures for MC4R are not yet available, which has hindered successful structure-based drug design. Using microsecond-scale molecular-dynamics simulations, we have investigated selective binding of the non-peptide antagonist MCL0129 to a homology model of human MC4R (hMC4R). This approach revealed that, at the end of a multi-step binding process, MCL0129 spontaneously adopts a binding mode in which it blocks the agonistic-binding site. This binding mode was confirmed in subsequent metadynamics simulations, which gave an affinity for human hMC4R that matches the experimentally determined value. Extending our simulations of MCL0129 binding to hMC1R and hMC3R, we find that receptor subtype selectivity for hMC4R depends on few amino acids located in various structural elements of the receptor. These insights may support rational drug design targeting the melanocortin systems.
topic MC4R
melanocortin-4 receptor
melanocortin-receptors
ligand binding
ligand selectivity
molecular dynamics
url https://www.frontiersin.org/article/10.3389/fphar.2018.00560/full
work_keys_str_mv AT noureldinsaleh bindingthermodynamicsandselectivityofanonpeptideantagonisttothemelanocortin4receptor
AT noureldinsaleh bindingthermodynamicsandselectivityofanonpeptideantagonisttothemelanocortin4receptor
AT gunnarkleinau bindingthermodynamicsandselectivityofanonpeptideantagonisttothemelanocortin4receptor
AT gunnarkleinau bindingthermodynamicsandselectivityofanonpeptideantagonisttothemelanocortin4receptor
AT nicolasheyder bindingthermodynamicsandselectivityofanonpeptideantagonisttothemelanocortin4receptor
AT nicolasheyder bindingthermodynamicsandselectivityofanonpeptideantagonisttothemelanocortin4receptor
AT timothyclark bindingthermodynamicsandselectivityofanonpeptideantagonisttothemelanocortin4receptor
AT peterwhildebrand bindingthermodynamicsandselectivityofanonpeptideantagonisttothemelanocortin4receptor
AT peterwhildebrand bindingthermodynamicsandselectivityofanonpeptideantagonisttothemelanocortin4receptor
AT peterwhildebrand bindingthermodynamicsandselectivityofanonpeptideantagonisttothemelanocortin4receptor
AT patrickscheerer bindingthermodynamicsandselectivityofanonpeptideantagonisttothemelanocortin4receptor
AT patrickscheerer bindingthermodynamicsandselectivityofanonpeptideantagonisttothemelanocortin4receptor
_version_ 1725589621987868672